INDIANAPOLIS (AP) -- European regulators approved the use of an imaging agent from Eli Lilly, which can help doctors diagnose Alzheimer's disease. The Indianapolis drugmaker plans to make Amyvid ...
INDIANAPOLIS, Oct. 19, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced they received a positive opinion ...
INDIANAPOLIS, Oct. 19, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced they received a positive opinion ...
Eli Lilly and Company ( LLY) recently announced the approval of its radioactive diagnostic agent, Amyvid (florbetapir F 18 Injection), by the European Commission (EC). Amyvid has been designed to help ...
The US Food and Drug Administration (:FDA) recently approved Eli Lilly and Company’s (LLY) radioactive diagnostic agent, Amyvid (florbetapir F 18 Injection). Amyvid has been designed to help detect ...
Last Friday, the FDA approved Amyvid, a drug for Alzheimer’s diagnosis that was created and developed by Penn faculty Daniel Skovronsky and Hank Kung. It dyes brain deposits of amyloid plaque, which ...
Amyvid™ (Florbetapir F 18 Injection) Approved in European Union for Use in Patients With Cognitive Impairment Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Impairment ...
The Centers for Medicare and Medicaid Services (CMS) is pursuing a National Coverage Determination (NCD) for monoclonal antibodies that clear amyloid beta plaque from the brain, such as aducanumab ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Eli Lilly’s imaging agent Amyvid, which ...
INDIANAPOLIS -- A European committee has endorsed the use of Eli Lilly and Co.'s imaging agent Amyvid for helping to diagnose Alzheimer's disease. The Committee for Medicinal Products for Human Use ...
European regulators approved the use of an imaging agent from Eli Lilly and Co., which can help doctors diagnose Alzheimer's disease. The Indianapolis-based drugmaker plans to make Amyvid available in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results